Trials / Completed
CompletedNCT00221052
Effect of Reduction of Inflammatory Status on Glucose Metabolism in Overweight Men
Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- TNO · Academic / Other
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Overweight increases the risk to develop chronic diseases including type-2 diabetes and cardiovascular disease. The low-grade inflammatory status often seen in overweight subjects is thought to play an important role in disease development. The purpose of this study is to determine the role of inflammation on glucose metabolism and insulin resistance. In this study the effect of the anti-inflammatory treatment diclofenac on markers of inflammation and on parameters of glucose metabolism will be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diclofenac |
Timeline
- Start date
- 2005-06-01
- Completion
- 2005-07-01
- First posted
- 2005-09-22
- Last updated
- 2006-10-11
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00221052. Inclusion in this directory is not an endorsement.